Effect of Orotic Acid on the Distribution of Phosphatidylcholine [32P]

Effect of Orotic Acid on the Distribution of Phosphatidylcholine [32P]

Japan. J. Pharmacol. 25, 345 (1975) SHORT COMMUNICATIONS EFFECT OF OROTIC ACID ON THE OF PHOSPHATIDYLCHOLINE DISTRIBUTION [12p] Isao NEGISH...

177KB Sizes 0 Downloads 37 Views

Japan. J. Pharmacol. 25, 345 (1975)

SHORT COMMUNICATIONS

EFFECT

OF

OROTIC

ACID

ON

THE

OF

PHOSPHATIDYLCHOLINE

DISTRIBUTION [12p]

Isao NEGISHI and Yoshio AIZAWA Department of Pharmacology, Tokyo College of Pharmacy, Shinjuku-ku, Tokyo, Japan Accepted February 10, 1975

Triglyceride accumulation in the liver can be brought about by a disease state in man, and by the administration of a large variety of agents (1, 2). A block in the release of hepatic beta-lipoprotein into blood stream appears to be responsible for the development of a number of experimentally induced fatty liver conditions (3). Our previous results demonstrated that a decreased release of beta-lipoprotein from liver slices in rats fed orotic acid was restored by the addition of phosphatidylcholine. It was further found that phospholipid has a curative effect on fatty liver induced by orotic acid or ethionine. These findings suggest that phospholipid is an important factor in the normal release of beta-lipoprotein. Accordingly, it is of interest to examine the fate of ingested phosphatidylcholine. The present experiments were done to examine the distribution of phosphatidylcholine [32P]in rats fed orotic acid. Female Wistar strain rats weighing 180 to 210 g were first fed a semisyntheticdiet (4) for 2 days. Control rats were given a semisyntheticdiet alone. Groups of animals then were put on a dietary supplement of I ;o orotic acid for 7 days after which 0.373 or 0.824 /iCi of phosphatidylcholine [32P]to which was added 14 mg of non-radioactive phosphatidyl choline as carrier in 0.5 nil of saline solution (1.91 or 4.23 /tCi/Kg body weight) was in jected intraperitoneally. At the indicated time after administration of the phospholipid, the rats were sacrificed by heart puncture under ether anesthesia. Tissues were removed, homogenized with ice-cold 5 trichloroacetic acid, and centrifuged. The precipitate was washed twice with ice-cold trichloroacetic acid. Lipids were then extracted once with 80% ethanol, once with 100% ethanol, twice with chloroform-ethanol (1: 1, by vol.), and once with ether. Trichloroaceticacid was added to the serum, and centrifuged. Serum lipids were then extracted with chloroform-methanol (2: 1, by vol.). Radioactivity of acid-soluble and lipid fraction was determined in a liquid scintillation spectrometer using dioxan and toluene-phosphor solution, respectively. Phosphatidylcholine [32P]was prepared as follows: Liver slices were incubated with 1.25 mCi orthophosphate [32P]per ml of Krebs-Ringer bicarbonate buffer at 37' in 02 CO2 (95: 5, by vol.) for 5 hr. Lipids were extracted as described above. Phosphatidyl choline was separated by paper chromatography according to the method of Marinetti et al. (5). The specificradioactivity of the prepared phosphatidylcholine[32P]was 18.41eCi/

SHORT TABLE 1.

Effect

CO111 Al UNICA

of orotic

acid

TIO.VS

Japan.

on the distribution

J. Pharinacol.

of phosphatidylcholine

25, 346 (1975, ['°P]

Value in the serum as dpm/ml serum. Each value represents mean standard error of 4 rats. * Mean significant difference from control (P<0 .05). ** Mean significant difference from control (P<0 .01). Rats were sacrificed 6 hr after administration of 0.373 1lCi of phosphatidylcholine [32P]to which was added 14 nagof non-radioactive phosphatidylcholine. Acid-soluble and lipid fractions were determined as described in Methods.

mg P.

The purity was checked by rechromatography.

found to be in the phosphatidylcholine

Over 90")/' of the radioactivity was

fraction.

As shown in Table 1, at 6 hr after administration of the phospholipid, the radioactivity in the lipid fraction of serum and liver decreased, but not that in the acid-soluble fraction. On the contrary, the incorporation

of phosphatidylcholine

[32P] into the lipid fraction of

adipose tissue was significantly increased by orotic acid.

However, orotic acid had no

effect on the incorporation of phosphatidylcholine

[32P] into both fractions of the spleen,

although a large amount of radioactivity was found.

The radioactivity in both fractions

of most other tissues was also unchanged by orotic acid, but that in acid-soluble fraction of the skeletal muscle was decreased. The radioactivity in lipid fraction of serum, liver, and adipose tissue at various periods after administration of phosphatidylcholine

[32P]is shown in Fig. 1.

In the serum lipid

fraction, the radioactivity in both control and rats fed orotic acid was highest at 3 hr and declined to 32 and 14° of the maximum value, respectively, at 24 hr.

At 3 hr, the incor

poration of phosphatidylcholine ['2P] into this fraction in rats fed orotic acid was more than that in the control, but the radioactivity in the rats fed orotic acid was less at 6 hr. At 12 and 24 hr, there was no difference in this fraction between control and rats fed oro tic acid.

In the liver lipid fraction, the highest radioactivity in both groups was found

at 6 hr after administration of phospholipid and then declined gradually. At 3 hr, the incorporation of phosphatidylcholine [32P] into this fraction in rats was also more than that in the control, but thereafter less radioactivity was observed as compared with the con trol.

In adipose tissues of rats fed orotic acid, the highest radioactivity was found 3 hr

after giving the phospholipid and then this level remained almost unchanged tip to 24 hr. In the control, the incorporation

of phosphatidylcholine

[32P] increased gradually with

SHORT

COJ%111IUNICATIONS

Japan. J. Pharnzacol. 25, 347 (1975)

FIG. 1. Effect of orotic acid on the incorporation of phosphatildylcholine [22P]into lipid fraction in serum, liver, and adipose tissue. Rats were given 0.824 pCi of phosphatidylcholine [32P] to which was added 14 mg of non-radioactive phosphatidylcholine. Each point represents the mean of 3 rats and the vertical lines represent standard error of the mean. •--• Control, 0-0 Orotic acid

time and the maximum

level was found

at 12 hr after administration

In an early stage, within 6 hr, the radioactivity higher

in this fraction

of the phospholipid.

of rats fed orotic acid was

than that in the control.

The results

of the present

study show that

the incorporation

of phosphatidylcholine

[32P] into lipid fraction but not into acid-soluble fraction in serum, liver, and adipose tissue was changed by ingestion of orotic acid. Changes in serum fraction by orotic acid are attributed

to the variation

of serum

lipoprotein

concentration,

since the absorption

of

phosphatidylcholine appeared to be unaffected by orotic acid. Accordingly, high radio activity in rats fed orotic acid at 3 hr after administration of phospholipid suggests that the releasa of lipoprotein lipid.

This suggestion

from the liver is facilitated

is further

tion of the liver and adipose administration

by the administration

by the fact that the radioactivity

tissue was also higher than that in the control

of the phospholipid.

thesis was proposed

supported

This effect disappeared

by Yagi et al. (6-8).

They suggested

within 6 hr.

of phospho in lipid frac at 3 hr after

A similar hypo

that phosphatidylinositol

plays

SHORT an important

COALUUNICATIONS

role in the release of beta-lipoprotein

Japan. J. Pharmacol. 25, 348 (1975) in fatty liver induced

by a low-protein

diet. Thus, perimental

the present

work demonstrates

that phospholipid

has a curative

fatty liver and that the effect is due to the release of lipoprotein

effect on ex from the liver.

REFERENCES 1) RoviLLER, C.H.: The Lii°cr, Edited by RoULLER,C.H., Vol. 2, p. 394, Academic Press, New York and London (1964); 2) SHAPIRO, B.: Lipids and Lipidoscs, Edited by SCILETTLER, G., p. 52, Springer-Verlag, Berlin, Heidelberg, and New York (1967); 3) LANIBORDI,B.: Fe(hi. Proc., 24, 1200 (1965); 4) HANDSCIIMMACHER, R.E., CREASEY,W.A., JAFFIi,J.J., PASTERNAK, C.A., AND HANKIN, L.: Proc. natty. Aca(I. Sci. 46, 128 (1960); 5) MARINETTI,G.V., ERBLAND, .1., AND KOCHEN, J.: Fe(In. Proc., 16, 837 (1957); 6) KOTAKi, A., SAKURAT,T., OKUMURA, M., AND YAGI, K.: Vitamins, 39, 168 (1969); 7) YAM, K., AND KOTAKI, A.: Ann. N.Y. Acad. Sci., 165, 710 (1969); 8) HASAN,S.H., NAKAGAWA,Y., NISHIGAKI,I., AND YAGI, K.: J. Vita minol., 17, 159 (1971)